Erythropoietin inhibits ferroptosis and ameliorates neurological function after spinal cord injury

Ferroptosis is one of the critical pathological events in spinal cord injury. Erythropoietin has been reported to improve the recovery of spinal cord injury. However, whether ferroptosis is involved in the neuroprotective effects of erythropoietin on spinal cord injury has not been examined. In this...

Full description

Bibliographic Details
Main Authors: Yu Kang, Rui Zhu, Shuang Li, Kun-Peng Qin, Hao Tang, Wen-Shan Shan, Zong-Sheng Yin
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Neural Regeneration Research
Subjects:
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=4;spage=881;epage=888;aulast=Kang
_version_ 1798021669724356608
author Yu Kang
Rui Zhu
Shuang Li
Kun-Peng Qin
Hao Tang
Wen-Shan Shan
Zong-Sheng Yin
author_facet Yu Kang
Rui Zhu
Shuang Li
Kun-Peng Qin
Hao Tang
Wen-Shan Shan
Zong-Sheng Yin
author_sort Yu Kang
collection DOAJ
description Ferroptosis is one of the critical pathological events in spinal cord injury. Erythropoietin has been reported to improve the recovery of spinal cord injury. However, whether ferroptosis is involved in the neuroprotective effects of erythropoietin on spinal cord injury has not been examined. In this study, we established rat models of spinal cord injury by modified Allen’s method and intraperitoneally administered 1000 and 5000 IU/kg erythropoietin once a week for 2 successive weeks. Both low and high doses of erythropoietin promoted recovery of hindlimb function, and the high dose of erythropoietin led to better outcome. High dose of erythropoietin exhibited a stronger suppressive effect on ferroptosis relative to the low dose of erythropoietin. The effects of erythropoietin on inhibiting ferroptosis-related protein expression and restoring mitochondrial morphology were similar to those of Fer-1 (a ferroptosis suppressor), and the effects of erythropoietin were largely diminished by RSL3 (ferroptosis activator). In vitro experiments showed that erythropoietin inhibited RSL3-induced ferroptosis in PC12 cells and increased the expression of xCT and Gpx4. This suggests that xCT and Gpx4 are involved in the neuroprotective effects of erythropoietin on spinal cord injury. Our findings reveal the underlying anti-ferroptosis role of erythropoietin and provide a potential therapeutic strategy for treating spinal cord injury.
first_indexed 2024-04-11T17:17:20Z
format Article
id doaj.art-d14e145fd4424ba395953a1ce4003318
institution Directory Open Access Journal
issn 1673-5374
language English
last_indexed 2024-04-11T17:17:20Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Neural Regeneration Research
spelling doaj.art-d14e145fd4424ba395953a1ce40033182022-12-22T04:12:36ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742023-01-0118488188810.4103/1673-5374.353496Erythropoietin inhibits ferroptosis and ameliorates neurological function after spinal cord injuryYu KangRui ZhuShuang LiKun-Peng QinHao TangWen-Shan ShanZong-Sheng YinFerroptosis is one of the critical pathological events in spinal cord injury. Erythropoietin has been reported to improve the recovery of spinal cord injury. However, whether ferroptosis is involved in the neuroprotective effects of erythropoietin on spinal cord injury has not been examined. In this study, we established rat models of spinal cord injury by modified Allen’s method and intraperitoneally administered 1000 and 5000 IU/kg erythropoietin once a week for 2 successive weeks. Both low and high doses of erythropoietin promoted recovery of hindlimb function, and the high dose of erythropoietin led to better outcome. High dose of erythropoietin exhibited a stronger suppressive effect on ferroptosis relative to the low dose of erythropoietin. The effects of erythropoietin on inhibiting ferroptosis-related protein expression and restoring mitochondrial morphology were similar to those of Fer-1 (a ferroptosis suppressor), and the effects of erythropoietin were largely diminished by RSL3 (ferroptosis activator). In vitro experiments showed that erythropoietin inhibited RSL3-induced ferroptosis in PC12 cells and increased the expression of xCT and Gpx4. This suggests that xCT and Gpx4 are involved in the neuroprotective effects of erythropoietin on spinal cord injury. Our findings reveal the underlying anti-ferroptosis role of erythropoietin and provide a potential therapeutic strategy for treating spinal cord injury.http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=4;spage=881;epage=888;aulast=Kangerythropoietin; ferroptosis; gpx4; iron overload; lipid peroxidation; mechanism; neurological function recovery; spinal cord injury; spinal neuron; xct
spellingShingle Yu Kang
Rui Zhu
Shuang Li
Kun-Peng Qin
Hao Tang
Wen-Shan Shan
Zong-Sheng Yin
Erythropoietin inhibits ferroptosis and ameliorates neurological function after spinal cord injury
Neural Regeneration Research
erythropoietin; ferroptosis; gpx4; iron overload; lipid peroxidation; mechanism; neurological function recovery; spinal cord injury; spinal neuron; xct
title Erythropoietin inhibits ferroptosis and ameliorates neurological function after spinal cord injury
title_full Erythropoietin inhibits ferroptosis and ameliorates neurological function after spinal cord injury
title_fullStr Erythropoietin inhibits ferroptosis and ameliorates neurological function after spinal cord injury
title_full_unstemmed Erythropoietin inhibits ferroptosis and ameliorates neurological function after spinal cord injury
title_short Erythropoietin inhibits ferroptosis and ameliorates neurological function after spinal cord injury
title_sort erythropoietin inhibits ferroptosis and ameliorates neurological function after spinal cord injury
topic erythropoietin; ferroptosis; gpx4; iron overload; lipid peroxidation; mechanism; neurological function recovery; spinal cord injury; spinal neuron; xct
url http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=4;spage=881;epage=888;aulast=Kang
work_keys_str_mv AT yukang erythropoietininhibitsferroptosisandamelioratesneurologicalfunctionafterspinalcordinjury
AT ruizhu erythropoietininhibitsferroptosisandamelioratesneurologicalfunctionafterspinalcordinjury
AT shuangli erythropoietininhibitsferroptosisandamelioratesneurologicalfunctionafterspinalcordinjury
AT kunpengqin erythropoietininhibitsferroptosisandamelioratesneurologicalfunctionafterspinalcordinjury
AT haotang erythropoietininhibitsferroptosisandamelioratesneurologicalfunctionafterspinalcordinjury
AT wenshanshan erythropoietininhibitsferroptosisandamelioratesneurologicalfunctionafterspinalcordinjury
AT zongshengyin erythropoietininhibitsferroptosisandamelioratesneurologicalfunctionafterspinalcordinjury